Table 1.

Outcome of fecal microbial transplantation for ulcerative colitis in randomised controlled trials.

Refs.	No. of cases (FMT: Controls)	Periods of UC patients	Route of administration and duration of treatment	Clinical remission	Endoscopic remission
Rossen et al. [82]	23 versus 25	Active	Nasoduodenal infusions twice (at start and 3 weeks later)	26•1% versus 32•0% (6 weeks)	–
Moayyedi et al. [83]	38 versus 37	Active	Enemas once weekly for 6 weeks	24% versus 5% (7 weeks)	24% versus 5% (7 weeks)
Paramsothy et al. [84]	41 versus 40	Active	Colonoscopic infusion followed by enemas 5 days per week for 8 weeks	44% versus 20% (8 weeks)	12% versus 8% (8 weeks)
Costello et al. [85]	38 versus 35	Active	Colonoscopic infusion followed by 2 enemas over 7 days	47% versus 17% (8 weeks)	11% versus 0% (8 weeks)
Sood et al. [86]	31 versus 30	Remission	Colonoscopic infusion every 8 weeks for 48 weeks	87•1% versus 66•7% (48 weeks)	58•1% versus 26•7% (48 weeks)